Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

John-Bjarne Hansen

Professor

UiT The Arctic University of Norway

Norway

Research Interests

Explore related searches

Professors in Norway

About

John-Bjarne Hansen is a Professor at UiT The Arctic University of Norway. His research focuses on thromboembolic disorders, particularly the risk factors associated with venous thromboembolism. Recent articles include studies on the impact of ischemic stroke, plasma levels associated with thromboembolism risk, and genetic influences on cardiovascular health. He is actively contributing to understanding the mortality risks associated with cancer-related venous thromboembolism.

Articles (10)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Collaborators (4)

Weihua Guan

Professor

Regents of the University of Minnesota

UNITED STATES

View details

Christian Jonasson

Senior Researcher

Norwegian University of Science and Technology

NORWAY

View details

David-Alexandre Trégouët

Team Director / 1st Class INSERM Research Director

INSERM U1219

FRANCE

View details

Philip Dusart

KTH Royal Institute of Technology

SWEDEN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

John-Bjarne Hansen

Research Interests

Explore related searches

About

Articles (10)

A multiomics approach reveals novel regulators of plasma factor V levels, highlighting CLEC4M as a clearance receptor.

Impact of ischemic stroke on the risk of venous thromboembolism in the general population: The Tromsø Study and The Trøndelag Health Study

Elevated Plasma MBL Levels Are Associated With Risk of Future Venous Thromboembolism: The HUNT Study.

Histo-blood group ABO system transferase plasma levels and risk of future venous thromboembolism: the HUNT study.

Joint effects of atrial fibrillation and prothrombotic genotypes on the risk of venous thromboembolism.

Resting Heart Rate and Risk of Incident Venous Thromboembolism: The Tromsø Study.

Plasma osteopontin levels are associated with the risk of future incident venous thromboembolism-the Trøndelag Health Study (HUNT).

Body height and risk of venous thromboembolism in men vs women.

Mortality risk after cancer-related venous thromboembolism has decreased over the last three decades: the HUNT and Tromsø studies.

Plasma miR-145-5p Levels and Risk of Future Cancer-Results from the HUNT Study.

Collaborators (4)

Weihua Guan

Christian Jonasson

David-Alexandre Trégouët

Philip Dusart

Make your next move.